Last quarter (Q0 0), Xeriant's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Xeriant's net income was $-364.85K. See Xeriant’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Total Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ 0.00
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ -76.00	$ ―
Gross Profit	$ ―	$ ―	$ ―	$ ―	$ 76.00	$ ―
Operating Expense	$ 1.95M	$ 1.91M	$ 2.05M	$ 11.01M	$ -2.20M	$ 362.74K
Operating Income	$ -1.95M	$ -1.91M	$ -2.05M	$ -319.19K	$ -3.01M	$ -362.74K
Net Non Operating Interest Income Expense	$ -1.22M	$ -1.18M	$ -10.57K	$ 4.81M	$ -12.48K	$ -364.98K
Other Income Expense	$ 17.85K	$ 20.30K	$ 4.26M	$ -58.21K	$ 216.69K	$ 28.16K
Pretax Income	$ -2.53M	$ -2.40M	$ -5.64M	$ -15.88M	$ -3.42M	$ -699.56K
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ 0.00	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -3.10M	$ -3.07M	$ -7.07M	$ -13.30M	$ -5.91M	$ -699.56K
Basic EPS	$ -0.02	$ ―	$ -0.02	$ -0.05	$ -0.01	$ -0.01
Diluted EPS	$ -0.02	$ ―	$ -0.02	$ -0.05	$ -0.01	$ -0.01
Basic Average Shares	$ ―	$ ―	$ 29.36M	$ 345.16M	$ 225.50M	$ 52.43M
Diluted Average Shares	$ ―	$ ―	$ 29.36M	$ 345.16M	$ 225.50M	$ 52.43M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 1.95M	$ 1.91M	$ 2.05M	$ 11.01M	$ -2.20M	$ 362.74K
Net Income From Continuing And Discontinued Operation	$ -3.14M	$ -3.10M	$ -7.10M	$ -13.30M	$ -5.91M	$ -699.56K
Normalized Income	$ -2.17M	$ -2.37M	$ ―	$ ―	$ ―	$ -727.72K
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ 364.98K
EBIT	$ -2.26M	$ -1.95M	$ -7.12M	$ -11.11M	$ -3.41M	$ -334.58K
EBITDA	$ -2.16M	$ -1.88M	$ -6.61M	$ -11.06M	$ -3.11M	$ -334.58K

Currency in USD

Xeriant Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing